Garcia-Rivas V, Fiancette J, Tostain J, de Maio G, Ceau M, Wiart J
Transl Psychiatry. 2024; 14(1):85.
PMID: 38336930
PMC: 10858238.
DOI: 10.1038/s41398-024-02774-6.
Patten T, De Biasi M
Neuropharmacology. 2020; 177:108162.
PMID: 32497589
PMC: 7814940.
DOI: 10.1016/j.neuropharm.2020.108162.
Talhout R, Richter P, Stepanov I, Watson C, Watson C
Tob Regul Sci. 2017; 4(1):592-604.
PMID: 29250577
PMC: 5730088.
DOI: 10.18001/TRS.4.1.6.
Vandaele Y, Janak P
Prog Neuropsychopharmacol Biol Psychiatry. 2017; 87(Pt A):22-32.
PMID: 28663112
PMC: 5748018.
DOI: 10.1016/j.pnpbp.2017.06.029.
Chiamulera C, Marzo C, Balfour D
Psychopharmacology (Berl). 2016; 234(9-10):1357-1370.
PMID: 27847973
DOI: 10.1007/s00213-016-4487-3.
Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy.
Robinson J, Versace F, Engelmann J, Cui Y, Gilbert D, Waters A
J Psychopharmacol. 2016; 30(7):627-40.
PMID: 27097731
PMC: 5858186.
DOI: 10.1177/0269881116642879.
Predicted Impact of Nicotine Reduction on Smokers with Affective Disorders.
Gaalema D, Miller M, Tidey J
Tob Regul Sci. 2015; 1(2):154-165.
PMID: 26236765
PMC: 4517852.
DOI: 10.18001/TRS.1.2.5.
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers.
McClure E, Baker N, Gipson C, Carpenter M, Roper A, Froeliger B
Am J Drug Alcohol Abuse. 2014; 41(1):52-6.
PMID: 25062287
PMC: 4262740.
DOI: 10.3109/00952990.2014.933839.
Nicotine content and abstinence state have different effects on subjective ratings of positive versus negative reinforcement from smoking.
Lindsey K, Bracken B, MacLean R, Ryan E, Lukas S, Frederick B
Pharmacol Biochem Behav. 2012; 103(4):710-6.
PMID: 23219727
PMC: 3565023.
DOI: 10.1016/j.pbb.2012.11.012.
A rodent "self-report" measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement.
Mahler S, Moorman D, Feltenstein M, Cox B, Ogburn K, Bachar M
Behav Brain Res. 2012; 236(1):78-89.
PMID: 22940018
PMC: 3482304.
DOI: 10.1016/j.bbr.2012.08.023.
Transient compensatory smoking in response to placebo cigarettes.
MacQueen D, Heckman B, Blank M, Van Rensburg K, Evans D, Drobes D
Psychopharmacology (Berl). 2012; 223(1):47-54.
PMID: 22427021
PMC: 3802524.
DOI: 10.1007/s00213-012-2685-1.
Role of cigarette sensory cues in modifying puffing topography.
Rees V, Kreslake J, Wayne G, OConnor R, Cummings K, Connolly G
Drug Alcohol Depend. 2012; 124(1-2):1-10.
PMID: 22365895
PMC: 3371306.
DOI: 10.1016/j.drugalcdep.2012.01.012.
Positive reactions to tobacco predict relapse after cessation.
Strong D, Leventhal A, Evatt D, Haber S, Greenberg B, Abrams D
J Abnorm Psychol. 2011; 120(4):999-1005.
PMID: 21574668
PMC: 4195596.
DOI: 10.1037/a0023666.
Nicotine reduction revisited: science and future directions.
Hatsukami D, Perkins K, Lesage M, Ashley D, Henningfield J, Benowitz N
Tob Control. 2010; 19(5):e1-10.
PMID: 20876072
PMC: 4618689.
DOI: 10.1136/tc.2009.035584.
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.
Hatsukami D, Kotlyar M, Hertsgaard L, Zhang Y, Carmella S, Jensen J
Addiction. 2010; 105(2):343-55.
PMID: 20078491
PMC: 4565618.
DOI: 10.1111/j.1360-0443.2009.02780.x.
Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women.
King A, McNamara P, Conrad M, Cao D
Psychopharmacology (Berl). 2009; 207(1):107-17.
PMID: 19756530
PMC: 4627785.
DOI: 10.1007/s00213-009-1638-9.
Contextual stimuli modulate extinction and reinstatement in rodents self-administering intravenous nicotine.
Wing V, Shoaib M
Psychopharmacology (Berl). 2008; 200(3):357-65.
PMID: 18587561
DOI: 10.1007/s00213-008-1211-y.
Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.
Tidey J, Rohsenow D, Kaplan G, Swift R, Adolfo A
Nicotine Tob Res. 2008; 10(6):1047-56.
PMID: 18584468
PMC: 2952171.
DOI: 10.1080/14622200802097373.
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Aubin H, Bobak A, Britton J, Oncken C, Billing Jr C, Gong J
Thorax. 2008; 63(8):717-24.
PMID: 18263663
PMC: 2569194.
DOI: 10.1136/thx.2007.090647.
Internal tobacco industry research on olfactory and trigeminal nerve response to nicotine and other smoke components.
Megerdichian C, Rees V, Wayne G, Connolly G
Nicotine Tob Res. 2007; 9(11):1119-29.
PMID: 17978985
PMC: 11200121.
DOI: 10.1080/14622200701648458.